Programmed Cell Death in Cancer Progression and Therapy
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Dordrecht :
Springer Netherlands : Imprint: Springer,
2008.
|
| Edición: | 1st ed. 2008. |
| Colección: | Advances in Experimental Medicine and Biology,
615 |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-1-4020-6554-5 |
Tabla de Contenidos:
- Cell Death: History and Future
- Caspase Mechanisms
- The Mitochondrial Death Pathway
- Apoptotic Pathways in Tumor Progression and Therapy
- Therapeutic Targeting of Death Pathways in Cancer: Mechanisms for Activating Cell Death in Cancer Cells
- Overcoming Resistance to Apoptosis in Cancer Therapy
- Trail Receptors: Targets for Cancer Therapy
- Rational Design of Therapeutics Targeting the BCL-2 Family: Are Some Cancer Cells Primed for Death but Waiting for a Final Push?
- Autophagy and Tumor Suppression: Recent Advances in Understanding the Link between Autophagic Cell Death Pathways and Tumor Development
- Regulation of Programmed Cell Death by the P53 Pathway
- Regulation of Programmed Cell Death by NF-?B and its Role in Tumorigenesis and Therapy
- Targeting Proteasomes as Therapy in Multiple Myeloma
- Histone Deacetylase Inhibitors: Mechanisms and Clinical Significance in Cancer: HDAC Inhibitor-Induced Apoptosis
- RNA Interference and Cancer: Endogenous Pathways and Therapeutic Approaches
- Cancer Stem Cells and Impaired Apoptosis.